Emergent BioSolutions [EBS] has acquired the assets and rights to a recombinant protective antigen (rPA) anthrax vaccine product candidate and related technology from VaxGen, Inc. [VXGN] for $2 million plus a potential additional $8 million in milestone payments. The arrangement also includes specified percentages of future net sales. VaxGen's original $877 million contract to develop and produce a next-generation anthrax vaccine was terminated by the Department of Health and Human Services in December 2006 due to stability issues with the…
Contract Updates
Intertrade Limited (Cedar Rapids, Iowa) – $9,272,637
Intertrade Limited, Cedar Rapids, Iowa, has been awarded a maximum $9,272,637 firm-fixed-price contract for F-16 generator controls. This was a sole-source acquisition using justification 10 U.S. Code 3204 (a)(1), as stated in Federal Acquisition Regulation 6.302-1. This is a four-year…
Cottonwood Inc. (Lawrence, Kansas) – $44,370,000
Cottonwood Inc.,** Lawrence, Kansas, has been awarded a maximum $44,370,000 firm-fixed-price, indefinite-quantity contract for aircraft cargo tie down straps. This was a sole-source acquisition using justification 10 U.S. Code 3204 (a)(5), as stated in Federal Acquisition Regulation 8.7. This is…
Teva Pharmaceuticals USA Inc. (Parsippany, New Jersey) – $46,087,497
Teva Pharmaceuticals USA Inc., Parsippany, New Jersey, has been awarded a maximum $46,087,497 modification (P00009) exercising the third one-year option period of a five-year base contract (SPE2DP-20-D-0002) with five one-year option periods for adenovirus type 4 and type 7 vaccines.…
Northrop Grumman Systems Corp. (Oklahoma City, Oklahoma) – $64,111,631
Northrop Grumman Systems Corp., Oklahoma City, Oklahoma, has been awarded an estimated $64,111,631 delivery order (SPRTA1-26-F-0034) and modification (P00015) to a four-year subsumable base contract (SPRTA1-19-D-0001) with one five-year option period for additional pricing for the manufacture and production of…